www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Share Buy-Back in ALK - release No 9

January 13, 2012

PDF Version

Supporting Materials:
AT_09_UK_13012011.pdf

 

Copenhagen, 2012-01-13 08:27 CET (GLOBE NEWSWIRE) --  

On 15 November 2011, ALK-Abelló A/S ("ALK") initiated a share buy-back programme, cf. company announcement No. 24 of 15 November 2011. According to the programme, ALK will in the period from 15 November 2011 to 30 April 2012 purchase own shares for a maximum amount of DKK 45 million and no more than 150,000 shares corresponding to 1.5% of the current share capital of ALK. The share buy-back programme is initiated and structured in compliance with the EU Commission Regulation No. 2273/2003 of 22 December 2003 and thus ALK will publish the accumulated share buy-back under the programme every week. 

 

Trading dayNo of shares
bought back
Average transaction priceAmount (DKK)
38: 6 Jan 2012 598319.84191,264
39: 9 Jan 2012 2,563319.72819,442
40: 10 Jan 2012 543319.50173,489
41: 11 Jan 2012 557321.61179,137
42: 12 Jan 2012 1,000325.00325,000
Accumulated for trading days 38-42 
5,261
 
320.91
 
1,688,332

 

The accumulated number of shares bought back in the period from 15 November 2011 to 12 January 2012 is 49,264 corresponding to a total purchase sum of DKK 15,571,517.

As of today, ALK's total holding of own shares is 276,239 shares of a nominal value of DKK 10, corresponding to 2.7% of the total number of issued shares of 10,128,360.

 

ALK-Abelló A/S
 

Jens Bager
President and CEO
 

For further information please contact:
Per Plotnikof, Investor Relations Director, tel. +45 4574 7527

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved